SCT: Checks and audits to improve quality and reduce risks
- Public Health England
- Part of:
- Sickle cell and thalassaemia screening: commission and provide and NHS population screening: failsafe procedures
- 15 March 2017
The NHS Sickle Cell and Thalassaemia (SCT) Screening Programme processes for ensuring a seamless and safe screening pathway.
Ref: PHE Publications gateway number: 2016644 HTML
Ref: PHE Publications gateway number: 2016644 MS Word Document, 143KB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
Each NHS screening programme has a defined pathway(s). The pathways show how the individual undergoing screening moves from one stage of the pathway to the next.
Checks are needed at each stage to ensure the individual moves seamlessly and safely through the pathway unless they choose not to. If these checks are not in place there is a risk that an individual does not complete the pathway or the pathway is delayed unnecessarily.
Published: 15 March 2017